These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 5408695)

  • 21. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells.
    Fishman DA; Bafetti LM; Stack MS
    Invasion Metastasis; 1996; 16(3):150-9. PubMed ID: 9186550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells.
    Horváth V; Blanárová O; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Fedorocko P; Kozubík A
    Gynecol Oncol; 2006 Jul; 102(1):32-40. PubMed ID: 16364413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of primary ovarian angiosarcoma with ifosfamide and doxorubicin.
    Cunningham MJ; Brooks JS; Noumoff JS
    Gynecol Oncol; 1994 May; 53(2):265-8. PubMed ID: 8188092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiotherapy as a cisplatin-sensitizer in a resistant ovarian carcinoma cell line.
    Siler DF; Wheeless CR; Dubin NH
    Cancer; 1996 May; 77(9):1850-3. PubMed ID: 8646684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The state of DNA in rapidly dividing cells].
    Kashkevich VS; Berdyshev GD; Salganik RI
    Biokhimiia; 1966; 31(3):548-55. PubMed ID: 5999945
    [No Abstract]   [Full Text] [Related]  

  • 26. Quantitative changes of nucleic acids in lymphocytes in culture under the influence of amethopterin.
    Urasiński I
    Folia Histochem Cytochem (Krakow); 1970; 8(3):321-7. PubMed ID: 5502307
    [No Abstract]   [Full Text] [Related]  

  • 27. Response of human ovarian carcinoma cell lines to antiprogestin mifepristone.
    Rose FV; Barnea ER
    Oncogene; 1996 Mar; 12(5):999-1003. PubMed ID: 8649817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the ets-1 proto-oncogene in human pancreatic carcinoma.
    Ito T; Nakayama T; Ito M; Naito S; Kanematsu T; Sekine I
    Mod Pathol; 1998 Feb; 11(2):209-15. PubMed ID: 9504693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GnRH agonist therapy in human ovarian epithelial carcinoma (OVCAR-3) heterotransplanted in the nude mouse is characterized by latency and transience.
    Peterson CM; Jolles CJ; Carrell DT; Straight RC; Jones KP; Poulson AM; Hatasaka HH
    Gynecol Oncol; 1994 Jan; 52(1):26-30. PubMed ID: 8307497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents.
    Kokkinakis DM; Ahmed MM; Delgado R; Fruitwala MM; Mohiuddin M; Albores-Saavedra J
    Cancer Res; 1997 Dec; 57(23):5360-8. PubMed ID: 9393761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effects of cytokines on ovarian and endometrial carcinoma cells in vitro with special reference to induction of specific transcriptional regulators.
    Seppänen M; Henttinen T; Lin L; Punnonen J; Grénman S; Punnonen R; Vihko KK
    Oncol Res; 1998; 10(11-12):575-89. PubMed ID: 10367939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure to enhance the in vivo killing of human ovarian carcinoma by sequential treatment with dequalinium chloride and tumor necrosis factor.
    Manetta A; Emma D; Gamboa G; Liao S; Berman M; DiSaia P
    Gynecol Oncol; 1993 Jul; 50(1):38-44. PubMed ID: 8349163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-resistance associated alterations of cell surface antigen expression in a human anthracycline-resistant ovarian carcinoma cell line.
    Sedlák J; McGown A; Hrubisko M; Hunáková L; Chorváth B
    Neoplasma; 1994; 41(5):259-62. PubMed ID: 7854495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
    Weckbecker G; Raulf F; Bodmer D; Bruns C
    Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of harringtonine on nucleotide metabolism in tumor cells].
    Yang SR; Fang FD; Wu GY
    Yao Xue Xue Bao; 1982 Oct; 17(10):721-7. PubMed ID: 7168320
    [No Abstract]   [Full Text] [Related]  

  • 37. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
    Lee FY; Borzilleri R; Fairchild CR; Kim SH; Long BH; Reventos-Suarez C; Vite GD; Rose WC; Kramer RA
    Clin Cancer Res; 2001 May; 7(5):1429-37. PubMed ID: 11350914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage.
    Yamanaka Y; Friess H; Buchler M; Beger HG; Uchida E; Onda M; Kobrin MS; Korc M
    Cancer Res; 1993 Nov; 53(21):5289-96. PubMed ID: 7693336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.
    Kozubík A; Horváth V; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Zák F; Mistr A; Turánek J
    Biochem Pharmacol; 2005 Feb; 69(3):373-83. PubMed ID: 15652229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the nucleic acid metabolism of the spleen of tumor-bearing rats.
    Pal M; Cliffton EE
    Pathol Eur; 1970; 5(3):253-9. PubMed ID: 5477022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.